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Bioscience and Economic Development: The Grand Rapids ‘Medical Mile’ 
 
Emily Vander Woude 
Grand Valley State University 
 
 
Michigan Street hill in Grand Rapids, Michigan has been dubbed the ‘Medical Mile’ because of the recent 
developments related to medical research and health care at this location. The impact of this growth is sure to 
change the face of Grand Rapids, but it is not clear how it will impact the economic situation there. Many other 
cities around the country and around the globe are putting investment into the bioscience, biotechnology, or life 
sciences sectoral strategy hoping that it will have a profound effect on their economic vitality. In this paper, I 
explore theoretical and practical perspectives on the crucial components that create a thriving bioscience cluster. 
After examining the broader international and national trends of success, this paper evaluates the collective impact 
of the biosciences on the Grand Rapids area through an assessment of the opportunities and constraints involved in 
the process.  This paper was originally submitted in a Masters level Economic Development course, but it is being 
further developed as the Grand Rapids “Medical Mile” unfolds as one of Michigan’s primary economic drivers. 
The most recent draft was submitted in April 2008 in the Public Management Seminar course required for 
completion of a Masters degree in Public Administration with an emphasis in Health Administration. It expands on 
the conditions and infrastructure of the Grand Rapids economic development strategy through the lens of the 
economic philosophy of “Wikinomics.” It delves into the changes that have occurred over the past year and 
examines what lies ahead.  
 
 
INTRODUCTION 
 
   The life sciences, or biosciences, have become the focus of many cities’ efforts to jumpstart their economies.  In 
the article entitled, “Cities and States Clamor to be Bio Town, U.S.A.” Pollack (2002) draws attention to the trend: 
“Cities and states across the United States are committing billions of dollars to become centers of the biotechnology 
industry, just as they once tried to attract computer and microchip companies to emulate Silicon Valley. The 
pioneers of the movement using life science as an economic development tool have been the Boston and San 
Francisco areas, who began in the 1970’s, while Seattle and Raleigh-Durham, North Carolina, New York, 
Philadelphia, Washington-Baltimore, and Los Angeles have also been leading close behind” (Pollack, 2002, p. 1).  
   It becomes evident that “bio” has become the new buzzword for local economies in the United States and abroad:  
“The Netherlands has its Bio-Delta; Switzerland has the BioAlps near Geneva and Basel's BioValley; Singapore 
claims to be "the Biopolis of Asia;” and even Saudi Arabia is laying plans for Jeddah BioCity” (Pollack, 2002, p.1). 
Is there enough evidence to support such concerted endeavors, or are cities setting themselves up for failure? In a 
2001 survey by Battelle for the Biotechnology Industry Organization, 41 states claimed that they were investing in 
life sciences (Pollack, 2002, p.1).  Is life science a sectoral strategy? What exactly is a biotech cluster?  What are the 
critical elements that advance a successful life sciences center?  Should there be hope for a significant return on 
investment in such projects?  
   This paper begins by defining the biosciences and discussing their emergence as a sectoral strategy in economic 
development.  It then evaluates several cities in the United States that have attempted to create and cultivate a life 
sciences center in order to better understand these endeavors and to gain an understanding of what it takes to create a 
thriving life sciences hub. It continues with a literature review that integrates both theory and case studies from 
several different locations in the United States and abroad.  The ultimate goal of this paper is to highlight the most 
important components that drive successful biotechnology clusters and to assess Grand Rapids’ opportunities and 
constraints in developing its life sciences corridor. Collaborative approaches will be explored in the context of the 
efforts of Michigan and Grand Rapids in the life sciences. News headlines from 2007-2008 will be compiled to 
determine the status of the Grand Rapids Medical Mile’s development.  Finally, this paper assesses the available 
data on Grand Rapids job growth and innovative capacity in order to create the building blocks for a longitudinal 
assessment of Grand Rapids’ successes and failures.  
 
The Biosciences/Life Sciences 
 
   What are the biosciences? According to Battelle, a nonprofit research institution that administered a survey on the 
subject in 2001, they are:   
A diverse group of industries and activities with a common link—they apply knowledge of the way in 
which plants, animals, and humans function. The sector spans different markets and includes 
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manufacturing, services, and research activities. By definition, the biosciences are a unique industry 
cluster and are constantly changing to incorporate the latest research and scientific discoveries. 
(“Growing the nation’s”, 2006, p. 1) 
  
The following table presents several examples of bioscience investments being pursued globally.  
 
Figure 1. A Sample of Biotech/life Sciences Parks Being Planned or Developed Around the World 
 
Name     Location   Investment 
East River Science Park   New York City, NY, USA  $700 million 
Beijing Bioengineering and 
   Pharmaceutical Industrial Base  Beijing, China   $241.5 million 
Medipark    Brno, Czech Republic  $200 million 
Thailand Science Park   Kllong Luang, Thailand  $175 million 
International Biotech Park   Hinjewadi, India   $140 million 
Life Science and Biotech  
   Center of Excellence   Astana, Kazakhastan  $50 million 
DuBiotech    Dubai, United Arab Emirates Data unavailable 
(Rinaldi, 2006, p. 133) 
 
Biosciences as a Sectoral Strategy 
 
   The biosciences have become what seems to be a popular economic development sectoral strategy in the United 
States and abroad. What makes a bioscience cluster a sectoral strategy? While the biosciences encompass a diverse 
selection of industries, as mentioned above, the bioscience strategy is a sectoral one because its focus is to cultivate 
an environment for a particular industry—the biotech/life sciences. While the term sectoral strategy is somewhat 
difficult to define given its many interpretations, sectoral strategies are all efforts to stimulate economic 
development in a particular area by fueling a particular sector or group of sub-sectors/industries that, when 
functioning together, create a hub of vitality.  
   Many times, sectoral strategies begin as public/private partnerships but usually one intermediary organization 
facilitates the sectoral strategy process. This organization can vary from a city or state government entity to a 
chamber of commerce, a community-based or nonprofit organization, to a university or community college 
(Fitzgerald & Green Leigh, p. 41). Many times the leader of the development partners with other public, private, and 
nonprofit organizations. Fitzgerald and Green Leigh (2002) explain that sectoral strategies among the nonprofit and 
foundation community “mean strategies that focus on creating employment opportunities for low income people” in 
a sector, focusing primarily on workforce development and augmenting the capacity of existing organizations (p. 
44). These strategies would fall under what Fitzgerald and Green Leigh coin “Type 1” strategies, those that “target 
existing industries in an economy and take measures to improve their productivity and create conditions for their 
growth” (p.40).  The biosciences sectoral strategy can be described as what the authors describe as a “Type 2” 
sectoral strategy because it usually focuses on drawing in new growth, stimulating the creation of new biotech spin-
offs, and focuses on high-paying, high-skilled jobs related to life sciences (p. 40). These “Type 2” strategies are 
many times initiated by city and state governments simply because not all community organizations have the 
resources to spearhead the attraction of high tech industries to the area. Governments can use resources such as land 
as well as tactics such as tax increment financing and networking capabilities to ease the process (p. 44-45). 
Fitzgerald and Green Leigh recognize that these “Type 2” strategies, through their focus on high-skills, high-paying 
jobs leave a need for job creation on all skill and pay levels, specifically to open opportunities for low-wage, low-
skill workers that are placed at a disadvantage.  Referencing their case study of New Haven, Connecticut, the 
authors underscore the importance of the development of workforce development strategies such as skills training 
for entry-level jobs, something that New Haven will have to deal with considering their 19.5% poverty rate, which is 
higher than the state and national averages of 8.3% and 11.8% (p. 64-65). Despite the success of New Haven’s 
biotech cluster, the city may have to compensate by supporting the population that does not benefit from the growth. 
“Type 2” strategies can have unintended negative consequences by reinforcing the separation between the rich and 
the poor.  
Theory and Practice 
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   Philip Cooke (2002), University of Wales, U.K., who has written extensively on the subject of biotechnology 
clusters, presents a theoretical and practical study about biotech clusters in the article, “Biotechnology Clusters as 
Regional Innovation Systems.” He first explains the significance of the “knowledge” economies in the global 
economy and then expands on biotechnology clusters in particular and the components that allow them to form and 
sustain themselves. He further illustrates his theories through the presentation of flourishing biotechnology clusters 
in Germany, Cambridge, Massachusetts, and Cambridge, U.K.  
   In explaining the multifaceted process involved in translating cluster development into tangible economic 
development success, he makes the following point: “to transfer science from the laboratory to the market involves 
complex interactive chains among scientists, entrepreneurs, and various intermediaries” (p. 8). He argues that 
regional economic systems have an advantage by explaining the features that commonly arise in tandem with their 
success, including but not limited to: agglomeration economies, institutional learning, associative governance, 
proximity capital, and interactive innovation (p. 10).  According to Cooke (2002), these components are not all 
necessary for a cluster development to form, but contribute greatly to their capacity to flourish in an increasingly 
competitive global environment.  He describes agglomeration economies as those with a ‘concentration of producers 
that support suppliers of specialized inputs,’ proximity being something that allows for the lessening of transaction 
costs between firms.  Institutional learning involved the creation of norms and ‘rules of the game’ between firms, a 
sort of shared organizational framework, something that he extended to describe the broader trend occurring 
globally.  Associative governance refers to the cooperative relationship between governments in a region as well as 
the ability for governments to ‘let go,’ or allow private entities to assume the role of a regional power player: 
Examples would include the role of a chamber of commerce or a business association.  Proximity capital refers to 
infrastructure in place that provides the necessary means to integrate elements needed to create a product or to 
provide a service: “The existence of appropriate communication links such as road, rail, airport, and 
telecommunications services is crucially important in proximity to industrial agglomerations” (p. 11).  The final 
component he describes is interactive innovation, a product of the interaction between the so-called ‘triple helix’ of 
organizations: industry, government, and universities.  A possible addition would be the nonprofit sector, an 
increasingly powerful player in economic development activity (p. 12).  Grand Rapids, in particular, has what may 
be called a “quadruple-helix” model, because of its philanthropic assets—non-profit organizations and foundations. 
Philanthropy has fueled much of the life sciences development—without these organizations, a piece of the puzzle 
would be missing.  
   Cooke (2002) holds that cluster development facilitates productivity, innovation, and new business formation if it 
is done in a particular way, and succeeds in creating the particular environment with fertile ground for a growing 
and thriving hub.  The following chart (Figure 1) shows Cooke’s criteria for a regional innovation system that is 
more likely to succeed as opposed to one that is likely to fail.  The overwhelming theme presented here is cohesion 
and synergy—these are components that Cooke finds to be crucial predictors of a booming regional innovation 
system or biotech center.  These factors must be integrated into spending, policy strategy, as well as the relationships 
between university and industry.  They must also be extended to the organizational culture of organizations (firms) 
and the broader context of organizational cooperation across sectors—be they public, private, or nonprofit 
organizations.     
   The areas that will be less likely to succeed are those that lack the essential connecting forces between people, 
ideas, capital, funding, skills, technology, etc. This leads one to ask the following question: What should be included 
as a recipe for an economically viable bioscience cluster? One of the key components that is prevalent in much of 
the literature regarding bioscience cluster development success is the cultivation of an environment that invigorates 
learning and innovation. Walcott (2002) includes the following statement in the article, “Analyzing an Innovative 
Environment: San Diego as a Bioscience Beachhead,” which explores the development of San Diego, California as a 
bioscience hub: 
Five factors are crucial for the development of a bioscience cluster: an outstanding research university with 
relevant specialty, a local entrepreneurial culture, strong advocacy leadership, available risk financing, and 
appropriate real estate (p.99).   
Walcott (2002) cites several other factors that contribute to the development of a thriving bioscience cluster, 
including a culture that allows for the possibility of failure, dynamic leadership and networking capability. San 
Diego was able to cultivate its bioscience cluster through taking advantage of these elements  (p.111). 
 
 
 
Figure 2. Conditions for Higher and Lower Regional Innovation Systems Potential 
   Higher Potential            Lower Potential 
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Infrastructural level   
    
   Autonomous taxing and spending        Decentralized spending 
   Regional private finance               National financial organization 
   Policy influence on infrastructure    Limited influence on infrastructure 
   Regional university-industry strategy      Piece meal innovation projects 
 
Super structural level 
  
   Institutional dimension 
 
      Cooperative Culture     Competitive culture 
      Interactive Learning     Individualistic 
      Associative Consensus     Institutional dissension 
 
   Organizational dimension (firms) 
 
      Harmonious labor relations    Antagonistic labor relations 
      Worker mentoring     Self-acquired skills 
      Externalization     Internalization 
      Interactive Innovation     Stand alone R & D 
 
   Organizational dimension (policy) 
      Inclusive      Exclusive 
      Monitoring      Reactin 
      Consultative      Authoritative 
      Networking      Hierarchical 
   
       
(Cooke, 2002, p. 15) 
    
   In an article in the Journal of Commercial Biotechnology examining the role of research institutions in 
Massachusetts, Nelsen (2005) notes the importance of educational institutions:  
 
The Boston/Cambridge area of Massachusetts has an unusually large concentration of world-class 
research institutions—universities and research hospitals—funded in large part by the US federal 
government, and particularly the National Institutes of health (NIH), to perform basic discovery 
research in biology and biomedicine. These include, among others, the Massachusetts Institute of 
Technology, the Whitehead Institute, Harvard University, Massachusetts General Hospital, Boston 
University and many others. Together, Massachusetts research institutions received over US $2.1 billion 
in NIH research grants in fiscal year 2003, approximately 10 percent of the national total. From this 
research comes much of the ‘feedstock’ for new biotech companies: new discoveries, intellectual 
property, knowledgeable scientific advisors for new companies and importantly, well-trained scientists 
to staff the new companies.   (Nelsen, 2005, p. 331) 
 
Fitzgerald & Green Leigh (2002) underscore the crucial component of the active presence and involvement of 
research institutions as well: 
 
Biotechnology, like high-tech industries, has location needs that preclude its locating in many places. A 
major research university is at the core of all biotechnology clusters and is a necessary, but not 
sufficient need. Once this requirement is met, state and local economic development policy can 
facilitate the expansion of biotechnology clusters in many ways.  (p. 54) 
 
Whether or not localities have all or some of the components that Cooke (2002) and Walcott (2005) describe as 
qualities that make a place more likely to succeed in biotechnology or life science development, the sector continues 
to grow and appears to be having positive benefits for communities. The Battelle nonprofit research group published 
the following findings in their report in 2006:  
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Total employment in the biosciences in the United States reached 1.2 million in 2004 (the latest year for 
which data are currently available), with bioscience workers found in all 50 states, the District of 
Columbia, and Puerto Rico…The nation’s 1.2 million bioscience jobs generated an additional 5.8 
million jobs in the economy, resulting in a total employment impact of 7 million jobs…. The average 
annual wage of bioscience workers in the United States was $65,775 in 2004, more than $26,000 greater 
than the average private sector annual wage…The bioscience industries as a whole are extremely 
profitable… Metropolitan areas of all sizes are heavily engaged in bioscience activities. While the five 
largest bioscience metro areas account for anywhere from 20 percent to nearly 40 percent of the total 
national employment in one particular sub-sector, these bioscience activities are widespread, with 
hundreds of metropolitan areas throughout the United States having some commercial or research 
involvement in the biosciences. In fact, 193 of the nation’s 361 metropolitan statistical areas have a 
specialization in at least one of the four biosciences sectors.  (“Bioscience,” p. 2-5)    
 
   The international, national, and local economic structure is certainly changing at a rapid pace, and collaborative 
structure and ideology is becoming ever more common as the economic system goes through a powerful 
metamorphosis. In the revolutionary book, Wikinomics: How Mass Collaboration Changes Everything,” written by 
Tapscott & Williams (2006), a new economic theory is born. The authors explain how this new economic 
framework is emerging, one that embraces the collaboration and synergy that are provided by the tools of innovative 
technology such as open source software, which embraces the connectivity of the internet to allow people to share 
knowledge and resources. They describe that:  
 
These changes, among others, are ushering us toward a world where knowledge, power, and productive 
capability will be more dispersed than at any time in our history—a world where value creation will be fast, 
fluid, and persistently disruptive. A world where only the connected will survive.  A power shift is 
underway, and a tough new business rule is emerging: Harness the new collaboration or perish. Those who 
fail to grasp this will find themselves ever more isolated—cut off from the networks that are sharing, 
adapting, and updating knowledge to create value.  (Tapscott & Williams, 2006, p. 12) 
 
Similar to Phillip Cooke, the authors claim that collaboration leads to gains in productivity and profit. Both 
Wikinomics and the “Triple-helix” that these authors describe are happening whether the critics like it or not. The 
case of Grand Rapids, Michigan is proving just that. In the following section, the evolution of the Grand Rapids 
Medical Mile will be examined through a review of the events and developments that have occurred from April 
2007 to April  2008. It will take a closer look at the collaborative structures that are emerging; it will break down the 
data on job growth and job projection, and it will examine how companies have been created and are growing.  
   The evidence shows that the city of Grand Rapids is changing rapidly in tandem with the global economy. It is not 
evident, however, whether or not the environment will allow for a true “quadruple-helix” collaborative structure to 
be embraced by all.  As the authors of Wikinomics claim, it is a given that change will occur, but it is not a given 
that cities, companies, organizations, and individuals will adapt accordingly. This sentiment is highlighted by the 
following paragraph:  
 
Now, to great chagrin, industrial-era titans are learning that the real revolution is just getting started. 
Except this time the competition is no longer their arch industry rivals; it’s the uber-connected, 
amorphous mass of self-organized individuals that is gripping their economic needs  firmly in one hand, 
and their economic destinies in the other. “We the People” is no longer just a political expression,  a 
hopeful ode to the power of the masses; it  is also an apt description of how ordinary people, as 
employees, consumers, community members, and taxpayers now have the power to innovate and to 
create value on the global stage....Companies can reach beyond their walls to sow the seeds of 
innovation and harvest a bountiful crop. Indeed, firms that cultivate nimble, trust-based relationships 
with external collaborators are positioned to form vibrant business ecosystems that create value more 
effectively than hierarchically organized businesses.......But the new participation will also cause great 
upheaval, dislocation, and danger for societies, corporations, and individuals that fail to keep up with 
relentless change. (Tapscott & Williams, 2006, p. 14-15) 
 
   Can Grand Rapids harness the potential to create a regional innovation system, a successful, booming life sciences 
corridor? While it is difficult and impossible to predict exactly the overall impact that the life sciences will have on 
the Grand Rapids area, it is helpful to evaluate and assess the collective developments, efforts and relationships 
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being formed to attempt to envision how these changes will affect the Grand Rapids community and to track them as 
they develop further.    
 
Opportunities and Constraints for the Grand Rapids Life Sciences Corridor 
 
Photo: Emily Vander Woude, April 23, 2008 
 
   The Michigan Economic Development Corporation (MEDC) has invested in the 21st Century Jobs Fund, an 
initiative that is attempting to use tobacco revenue to invest in four target sectors, one of them being the life 
sciences. MEDC has also created the Smart Zone program that uses tax increment financing to particular areas 
where biosciences are being pursued. “Biotech Connect,” a part of this effort, seeks to provide entrepreneurs with 
the needed support to start up their bioscience businesses (“Bioscience” p. 1-2). The Smart Zone provides incentives 
for business start ups.      
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 Photo: Emily Vander Woude, April 23, 2008 
 
   In assessing the opportunities that Grand Rapids has for success, it is evident that Grand Rapids has several 
components that were noted earlier as prerequisites or predictors for success. Grand Rapids has a strong base of 
philanthropy, from the Van Andel Institute to the Helen Devos Children’s Medical Tower, to St. Mary’s Hauenstein 
Center, to the GVSU Cook-Devos  Health Center—the big names that have provided the funds are major players in 
the life science corridor’s development.   
   The private funding sources give Grand Rapids an advantage over other areas. Many localities simply do not have 
the generous philanthropic resource that Grand Rapids is fortunate to possess. The local philanthropic funds have 
spurred the rapid growth of projects that may have been hindered by the lack of state and local funding available.  A 
project like Van Andel Institute would not have been possible without extensive private capital.  As mentioned 
before, many cities cannot engage in the trial and error involved in the life sciences sectoral strategy.  Grand Rapids 
has been fortunate enough to gain the cushion provided by philanthropic revenue and can afford to take such risks.    
    The nonprofit organization The Right Place has been also been a leader in economic development efforts. In their 
most recent annual report (2006), The Right Place notes the more than one billion dollars in life science investment 
that is happening in Grand Rapids as well as the “manufacturers throughout the area that continue to leverage their 
expertise in sophisticated metals, plastics and medical device manufacturing to develop new market opportunities” 
(“Right Place,” 2006, p. 9).  The report continues to describe the Innovation WORKS program that was initiated by 
the Right Place in 2006.  This program is a regional collaborative effort between The Right Place, Lakeshore 
Advantage, an economic development organization serving the Holland, Zeeland, and Saugatuck, Michigan areas, 
and Grand Rapids Community College created to build the necessary foundation for commercialization among 
firms.  The project is funded by part of a 15 million dollar grant from the U.S. Department of Labor, one of the 12 
West Michigan Strategic Alliance’s (WMSA) WIRED (Workforce Innovations in Regional Economic 
Development) West Michigan efforts to revitalize the economic base through workforce development, economic 
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development strategy, and education (“Right Place,” 2006, p.9).  The Right Place report further describes the 
Innovation WORKS program expanding on its regional cooperative efforts toward commercial and societal benefit:  
 
Targeted to advanced manufacturing as well as emerging industries, Innovation WORKS will not only 
expand the infrastructure for start-up businesses and improve the competitiveness of area firms; it will also 
raise the region’s profile as an innovative, attractive business location. Its four components include: A 
region-wide Commercialization Infrastructure that will organize current and future resources to accelerate 
the commercialization of intellectual property in Michigan, a regional Design Council to increase the supply 
and use of industrial and other design skills in area companies, a series of Innovation Forums featuring 
world-class thinkers on innovation strategies to educate and help area firms adopt new practices, and an 
Innovative Curriculum of learning programs to help the skills needed to support innovation strategies, 
systems, and practices.  (p. 9)  
 
The Right Place has been involved in many integrating economic development strategies such as this one that focus 
on regional rather than competitive strategies. It appears that initiatives such as this project are attempting to foster 
the kind of learning environment that Cooke (2002) describes as a crucial component to regional innovation system 
success and survival.   
   The Grand Rapids/ Kent County Smart Zone is another effort that has been developed for economic development 
purposes by the City of Grand Rapids, Grand Rapids Community College, Grand Valley State University, The Right 
Place Program and the Van Andel Institute (VAI).  In “Smart Zones and technology-based economic development: 
technology-led economic development in Michigan and other mid-western states,” Johnson & Singh (2003) describe 
the Grand Rapids Smart Zone below:  
  
This zone seeks to stimulate the growth of technology-based businesses and jobs in the Grand Rapids area. It 
will build upon the singular strength of the VAI, a sustained rebirth of downtown Grand Rapids, and the 
regional institutions of higher education. The zone will also support the growing needs of the new life 
sciences enterprises developed through the establishment of a life sciences development center, to include a 
full-service incubation center.  (p. 1)   
 
Critics of the Smart Zone argue that it would reinforce socioeconomic inequality by benefiting a highly skilled 
workforce and leaving out people with lower skills and less education. Not only will it do this, but because it is a tax 
increment financing zone, it would not extend the taxes to the areas that are in dire need of tax revenue such as the 
failing Grand Rapids Public School system. While there are those who boast about the money coming into the city 
with the Helen Devos Children’s Hospital at $250 million, the Van Andel new construction ($165 million), St. 
Mary’s Hauenstein Center ($60 million), the slated MSU medical school—it is hard to decipher who will be the 
direct beneficiaries of the profits. Will there be significant positive externalities to justify the use of the Smart Zone 
tax incentives? Those who argue that the overall life sciences efforts are worth it underscore the importance of an 
innovative organization such as the Van Andel Institute:  
 
The Van Andel Institute is an important asset in making Grand Rapids more attractive to life-sciences 
companies…The Van Andel Institute is different from other Life-Sciences facilities, in that it does not 
serve a local clientele but draws new money into the area in the form of research grants to find 
treatments for cancer, Parkinson’s and other diseases. Discoveries by the institute’s scientists could 
attract new business from pharmaceutical and medical device companies.  (Shellenbarger, 2007, p. A1)  
 
   The West Michigan Science and Technology Initiative (WMSTI) is housed in Grand Valley State University’s 
Cook-Devos Center for Health Sciences. It is a partnership that was formed in 2003 between The Right Place, Van 
Andel Research Institute, Grand Valley State University, the City of Grand Rapids, and Grand Rapids Community 
College and has recently drawn in Spectrum Health, Saint Mary’s, Mary Free Bed Rehabilitation Hospital, and the 
Grand Angels. The partnership was formed to “bring together the product development tools, amenities, and 
community assets an innovator, entrepreneur, or small business needs to make their ideas a business reality. WMSTI 
also caters to client needs by offering incubator/accelerator amenities through the Product Development Center 
located in the Cook-Devos building” (“WMSTI”, 2007). 
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Photo: Emily Vander Woude, April 23, 2007 
 
   In an article about the Michigan Department of Transportation’s plan to widen ‘key sections of vital city streets,” a 
total investment of $400 million that will include $3.75 million of reconstruction on Michigan Street, Guy (2006) 
explains the debate that arose over whether or not this would have a positive or negative impact on the city of Grand 
Rapids. Those in favor of less travel time on the highways and major city roads are proponents, while those that 
believe mass transit is where the state should be investing its money are discouraged by the plans. Some argue that 
the overwhelming focus on automobile transit ignores the need to facilitate other important modes of transit such as 
walking, biking, bus, or street car—citing major metropolitan areas where this is the norm ( p. 1-3).  For now, it 
seems that Grand Rapids will continue to be an auto-centered environment, something that may be to its detriment 
in attracting and retaining high-skills labor.  Michigan State University’s plan to come to Grand Rapids is a major 
asset of the Medical Mile and may override the detraction of the widened road:  
 
The Grand Rapids building that will become the new home of the MSU College of Human Medicine will be 
named “The Secchia Center,” in recognition of a gift from alumnus Ambassador Peter F. Secchia that will total 
$20 million toward the $40 million in private support required to complete the project. The Secchia Center will 
include research and teaching laboratories, classrooms, offices and student areas. Michigan State’s College of 
Human Medicine is slated to enroll its first class of 100 first-year students in Grand Rapids in 2010, when the 
new facility opens, and second-year students will begin study there in 2008 in a leased facility. Once the 
program is at full capacity, enrollment in Grand Rapids will exceed 400 students.  ("Secchia”, 2007) 
 
MichBio , as an affiliate of  Biotechnology Industry Organization, BIO, which represents biotechnology companies 
across America and in 33 other nations, is:  
 
a non-profit, statewide trade association, headquartered in Ann Arbor, MI. Formed in 1993 as the Michigan 
Biosciences Industry Association, MichBio’s mission is to drive life sciences industry growth in Michigan by 
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providing its members with: networking & educational opportunities, legislative & business advocacy & 
public awareness efforts,  a hub for life sciences information and comments, and power buying resources. Its 
members are life sciences companies, academic and research institutions, bioscience service providers, and 
related organizations. (Michbio, 2008) 
 
As part of its efforts, MichBio created an online directory of all of the life science companies in Michigan. 
Following is a table that displays the companies, universities, and other organizations that engage in activity related 
to life sciences in Grand Rapids, Michigan. See Figure 3. 
 
 
Figure 3. MichBio Directory of Grand Rapids (MSA) Life Sciences Organizations 
 
Directory of Life Sciences Organizations 
Company/Organization Category 
ATEK Medical Manufacturing Contract Manufacturing/Production 
Avalon Laboratories, Inc General 
Bio-Chem Environmental Analytical Laboratories General 
Cascade Life Solutions General 
ClinXus Research Institute 
Core Technology Alliance Research Institute 
Corium International, Inc. Biopharmaceutical 
Elkins Innovations, Inc . Prosthetics/Orthotics 
Gerontology Network General 
Grand Rapids Community College University 
Grand River Aseptic Pharmaceutical Packaging, Inc Pharmaceutical 
Grand Valley State University University 
Haviland Enterprises Contract Manufacturing/Production 
Hopen Therapeutics General 
Medbio, Inc Contract Manufacturing/Production 
Medtronic General 
Michigan Antibody Technology Center General 
Michigan Instruments General 
Michigan Medical PC General 
Optical Supply General 
Surge Medical Solutions General 
Van Andel Research Institute General 
Vital Concepts, Inc. General 
West Michigan Regional Laboratory Healthcare & Technology 
(MichBio, 2008)  
   
  This may not be an all-inclusive list—as the economy is constantly evolving, it will be of crucial importance to 
continue to follow these organizations and their relationships to one another to get the full picture of the Grand 
Rapids life sciences sector’s development. 
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   A non-published data file from the Community Research Institute at the Johnson Center for Philanthropy at Grand 
Valley State University provides data on the number of employable graduates in the life sciences field. The 
methodology used is as follows:  Data was downloaded from the Bureau of Labor Statistics on job growth 
projections for the Grand Rapids Metropolitan Statistical Area (MSA). Jobs that had less than 25% growth and jobs 
with less than 100 jobs added over the term (not annually) are excluded.  The Standard Occupational Occupation 
codes are compared with the Bureau of Labor Statistic codes.  The major group occupations, nonspecific 
occupations are also excluded. For remaining occupations, the titles are compared to the Integrated Postsecondary 
Education Data System (IPEDS) fields of study to find the best fit. It is noted that some occupations do not have an 
IPEDS field of study because there is no relevant college coursework. Finally, projected annual openings for each 
opening are compared with the respective degree/certificate completions and the lesser of the two figurines is the 
Employable Graduates number (the number of people who could possibly fill the projected positions available). 
Figure 4 shows the Employable Graduates in the health field: 
 
 
 
 
 
 
 
 
 
 
Figure 4. Grand Rapids (MSA) Employable Graduates in Health Field 
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Occupational Projections with 
>24% and 100 Jobs Growth 2004-
2014 Local County Completions 
Employable 
Graduates 
SOC 
Occupational 
Title 
Annual 
Average 
Openings Major 2003-2004  
2004-
2005  
2005-
2006  2004 2005 2006 
291071 Physician 
Assistants 
14 Physician Assistant 27 28 26 14 14 14 
291111 Registered 
Nurses 
358 Nursing/Registered Nurse 
(RN, ASN, BSN, MSN) 
269 361 348 269 358 348 
291123 Physical 
Therapists 
18 Physical Therapy/Therapist 47 47 46 18 18 18 
292021 Dental 
Hygienists 
27 Dental Hygiene/Hygienist 25 30 31 25 27 27 
292071 Medical 
Records/Health 
Info Technicians 
24 Health Information/Medical 
Records 
Technology/Technician 
130 33 29 24 24 24 
311011 Home Health 
Aides 
75 Home Health Aide/Home 
Attendant 
0 0 0 0 0 0 
319091 Dental 
Assistants 
80 Dental Assisting/Assistant 113 258 107 80 80 80 
319092 Medical 
Assistants 
92 Medical/Clinical Assistant 485 990 510 92 92 92 
(Community Research Institute, 2008) 
 
Since 2007, the headlines regarding job growth, profit-making, and collaborative activities have regularly surfaced 
in the Grand Rapids media circuit. Rapid Growth is a weekly e-magazine and web site “devoted to showcasing the 
positive and sustained transformation of the greater Grand Rapids region” (Rapid Growth, 2008)  Reviewing Rapid 
Growth headlines in the past year provides  an overview of the recent developments related to health care and life 
sciences in Grand Rapids. While other local media outlets such as the Grand Rapids Press and the television 
networks cover these stories, Rapid Growth interviews the specific organizations regarding their economic 
development activities more thoroughly.  Appendix A displays the highlights of the past year from the Rapid 
Growth e-newsletter in their weekly headlines. This compiled list provides a snapshot of the developments of the  
Medical Mile – jobs gained, discoveries made, new programs, etc.  
 
CONCLUSION 
 
   Michigan Street is blossoming into a hub of economic activity and a topic of discussion for Grand Rapids 
residents, leaders, and entrepreneurs. Since April 2007, many developments have ensued and many relationships 
have been forged. This is clearly reflected in the news headlines found in Appendix A. Collectively, the health care 
developments—philanthropic, governmental, private, and on the university level— have rapidly changed the face of 
Grand Rapids and continue to do so. Will Grand Rapids manage to sustain its life sciences cluster?  Further analysis 
and longitudinal data on demographics and employment changes will be required to determine what is to be the 
ultimate impact of the Grand Rapids Medical Mile. At this time; however, it is evident that Grand Rapids managed 
to create a “quadruple-helix” in the collaboration between its universities, public, private, and nonprofit 
organizations—creating an ever-changing “Medical Mile” on Michigan Street.  What other cities can learn from 
Grand Rapids: It is possible to find synergy between organizations and individuals which results in massive profit 
that extends beyond monetary gain to give birth to new and innovative discoveries—despite the critic’s belief to the 
contrary.  
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APPENDIX A 
 
Rapid Growth News Headlines for Grand Rapids (MSA) 
Rapid Growth News Headlines 2007-2008 
Date Headline Highlights 
26-Apr-07 WMSTI leverages 
over $23M for life 
sciences startups, 
pursues patents 
In the last five years, the West Michigan Science and Technology Initiative 
(WMSTI) has helped life sciences start-ups procure more than $20 million in 
investment, some $3 million in grants, and helped one business license their first 
product with a $13-billion-dollar corporation. 
3-May-07 GR medical 
manufacturer 
expects to create 15 
jobs 
The silicone tubes Rose Technologies makes are components for catheters. The 
company's manufacturing method revolutionized the product and launched their 
business. Now, nine years later, they make 200 different medical components for 
finished goods manufacturers like ATEK Medical Manufacturing and Medtronic, 
they have 25 employees, and posted 2006 sales just under $2 million. 
3-May-07 $6M venture moves 
GR into molecular 
medicine 
A $6 million joint venture between Spectrum Health and the Van Andel Institute 
will offer cutting-edge molecular medicine capabilities. The Center for Molecular 
Medicine (CMM) will aid in early diagnosis and improved treatments for cancers, 
heart disease, mental illness, and other complex diseases. 
10-May-07 GR molecular drug 
testing in top 10 
percent 
Out of about 350 molecular medicine centers in the country, Grand Rapids’ Center 
for Molecular Medicine is in the leading ten percent to offer genetic testing that 
determines a patient’s compatibility and non-compatibility with certain prescription 
drugs. 
10-May-07 Life-changing 
prosthetic hand 
could garner $20M 
annually 
Today, hand and arm amputees have just three options when it comes to 
prosthetics: one that is merely cosmetic, one that opens and closes by mechanically 
controlling a harness, and one that opens and closes by way of sensors glued on the 
skin over certain muscles. The first has no practical function, and the others have 
limited functions that are difficult to master. Elkins Innovations, Inc., 301 
Michigan NE, is about to change all that. A new prosthetic hand the company is 
developing will control an unprecedented eight functions: wrist flexion (up and 
down), thumb movement (in and out), and individual movement of each finger.  
10-May-07 W MI 1.4M patient 
population gains 
early access to 
advanced medicine 
West Michigan’s 1.4 million healthcare patient population is expected to benefit 
from advanced medical treatments sooner than the general population. ClinXus, a 
partnership of several West Michigan medical facilities—among them are the Van 
Andel Institute, Spectrum Health, Saint Mary’s Health Care, and the Jasper 
Clinic—expects to bring cutting edge treatments to some patients seven to eight 
years sooner than they would normally be able to receive them if they lived 
somewhere else. 
21-Jun-07 Suburban GR 
company relocates 
downtown, brings 
75 employees 
ProCare Systems Corporation is a medical practice management corporation with a 
nice office near Centerpointe Mall. But the business needs room to grow, so it's 
heading downtown and bringing 75 employees along. 
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28-Jun-07 As medical industry 
booms, GR 
packaging firm 
plans to hire 60 
To say that Grand Rapids-based Praxis is in growth mode is an understatement. 
The company quadrupled its annual sales in the past two years, hired 115 workers 
this year alone, and now plans to add some 60 more by year's end. 
Praxis is a contract packaging company that began in the late 1980s offering 
packaging and point of purchase displays for over the counter drug manufacturers. 
The company recently expanded its services to include packaging for prescription 
pharmaceuticals, which has become its fastest growing market.  
12-Jul-07 State considers $8M 
fund to finance life 
sciences startups 
In an effort to retain life sciences technicians who lost their jobs when Pfizer 
downsized in Holland, Kalamazoo, and Ann Arbor, the state has proposed a pool of 
$8 million from the 21st Century Jobs Fund to entice those workers to stay in 
Michigan and develop their own life sciences companies. The money is part of a 
$12 million allocation for a Pfizer retention initiative. 
12-Jul-07 From GR to Detroit, 
21 cutting-edge labs 
lure life sciences 
entrepreneurs 
A consortium of 21 laboratories across the Michigan life sciences corridor are 
available to entrepreneurs to research, test, develop, and even package clinical 
products. The Core Technology Alliance (CTA), which is housed at the Van Andel 
Institute in downtown Grand Rapids, is making it easier for life sciences startups to 
make their product without building an expensive laboratory many can't afford. 
19-Jul-07 Medical 
manufacturers team 
up to capture 
potential $500M in 
sales 
Seven West Michigan medical device manufacturers recently formed a coalition, 
West Michigan Medical Device Consortium (WMMDC), to encourage 
collaboration, help leverage individual strengths, and grow their businesses. The 
West Michigan Science and Technology Initiative (WMSTI), part of Grand Valley 
State University, is putting together the strategic plan and helping the consortium 
get off the ground. 
26-Jul-07 Van Andel Institute 
researchers step 
closer to drug for 
prostate cancer 
Scientific Investigator Dr. Cindy Miranti and her team at the Van Andel Research 
Institute have taken a major step forward on their quest to develop a drug to treat 
prostate cancer. 
26-Jul-07 Medbio hires 5, will 
add 4 more jobs by 
year’s end 
“Astounding” might be the word Chris Williams, president of Grand Rapids-based 
Medbio, would use when describing his company’s growth this year. Williams 
expects 2007 sales to exceed a 100 percent increase when compared to the 
company's 2006 performance, approaching some $4 million by the end of the year. 
And if that isn’t astounding enough, Williams is predicting 20 percent to 40 percent 
growth in ’08 and ’09. 
2-Aug-07 Educational 
leadership initiative 
gets $2.3M for math 
and science training 
With high-tech jobs, life sciences careers, and medical device manufacturing and 
engineering on the rise, the success of Michigan’s knowledge economy is 
dependent on the availability of qualified science and mathematics professionals. 
GVSU, the University of Michigan and University of Michigan-Dearborn, Saginaw 
Valley State University, and the Michigan Mathematics and Science Center 
Network joined forces with targeted high-needs schools statewide and college and 
university math and science experts to form the collaborative. Funding comes from 
a $2.3 million two-year grant from the Michigan Department of Education, with 
the possibility of renewable grants of $4.5 million. 
2-Aug-07 GR’s Surge Medical 
on track for 40 
percent growth and 
more employees 
The leaders at Surge Medical in Grand Rapids still consider the two-year-old 
medical device manufacturer a start-up. But since acquiring a product line 12 
months ago, the company has been on an upward climb on the sales charts. 
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16-Aug-07 West Michigan's 
life sciences 
industry sixth 
largest in the nation, 
and growing 
The region is the sixth largest biopharmaceuticals cluster in the US, with a recent 
investment of over $1 billion in life science endeavors. In addition, there are over 
850 clinical trials currently open in West Michigan. 
23-Aug-07 Spectrum Health 
among first in MI to 
offer alternative hip 
replacement 
procedure 
In May 2006, the FDA approved the Birmingham Hip Resurfacing (BHR) implant 
and procedure for use in the US. In September, Dr. Thomas Malvitz, M.D. was in 
Birmingham, England training under the doctor who created the implant and 
surgical technique. Since then, Dr. Malvitz, chair of Spectrum Health's Orthopedic 
Department and a physician with Orthopedic Associates of Grand Rapids, has 
performed 25 BHR implant procedures. 
23-Aug-07 Center for 
Molecular Medicine 
pioneers test to 
protect nursing 
infants 
This week, the Grand Rapids-based Center for Molecular Medicine (CMM) 
announced it is the only lab in the Midwest with the capability to test nursing 
mothers for codeine risks that can cause morphine overdoses in nursing infants. 
When codeine is metabolized, it becomes morphine. People with a variation in a 
liver enzyme called CYP2D6 may change the codeine to morphine more quickly 
and completely. 
30-Aug-07 VARI Graduate 
School welcomes 
first two students 
Last week, the new Van Andel Institute Graduate School (VAIGS) accepted its 
first two students with a convocation signaling the beginning of the academic year. 
The VAIGS received an independent charter from the State of Michigan to confer 
advanced degrees in biomedical research of various human diseases. 
30-Aug-07 Collaborative life 
sciences initiatives 
blaze trails to new 
businesses, jobs 
Collaboration between business competitors is unheard of in most parts of the 
country. But in West Michigan, it's becoming the norm, especially in the life 
sciences industry.  One example is the West Michigan Science and Technology 
Initiative (WMSTI), which was established by the State of Michigan in 2002 as a 
life sciences incubator to help entrepreneurs and innovators get their products and 
discoveries to market.  "We've got competitors working together for the greater 
good of the community, and that's what West Michigan is built on," says Kim 
Bode, marketing director. "That sets us apart."  Bode cites a number of joint efforts 
across the region that are primed to spur economic development throughout the 
gamut of life sciences technologies: 
 
    * The Right Place, Inc. and Southwest Michigan First are working together to 
       attract and retain businesses. 
    * ClinXus, a clinical research alliance, is attracting pharmaceutical companies to 
       do clinical research. 
    * The Core Technology Alliance connects core efficiencies between companies 
       to drive drug development through the pipeline faster. 
    * West Michigan Medical Device Consortium is a group of manufacturers 
       working together to leverage core competencies and create awareness of the 
       region's manufacturing expertise. 
    * Biotech Commercialization Project sets up innovation committees to get  
       healthcare workers' biotech inventions to market. 
30-Aug-07 VARI scientists 
closer to finding 
leukemia gene 
Researchers at Grand Rapids-based Van Andel Research Institute may have 
pinpointed the gene that causes myeloproliferative disease (MPD) and 
myelodysplastic syndrome (MDS), two bone marrow cancers formerly known as 
pre-leukemia. The discovery could be a major step in helping physicians determine 
if a patient has the potential to develop acute leukemia. 
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20-Sep-07 VAI honors two 
renowned 
researchers for 
cancer prevention 
discoveries 
Last week the Van Andel Institute (VAI) honored two renowned researchers who 
were instrumental in investigating human papillomavirus (HPV) and its links to 
cervical cancer with the Daniel Nathans Memorial Award. The VAI's Board of 
Scientific Advisors presents the award each year for far-reaching contributions in 
biomedical and cancer research that have a significant benefit to public health. 
20-Sep-07 Women's Health 
Center could bring 
50 new jobs to 
downtown Grand 
Rapids 
Construction of the five-story, 110,000-square-foot Women's Health Center at 
Union and Michigan Streets in Grand Rapids is well underway and 70 percent of 
the space already is pre-leased. Even with 30,000 square feet still available, 
developer Michael Garrett expects the businesses and health practices already on 
board will generate approximately 50 new jobs. 
18-Oct-07 Michigan firm 
launches two 
cutting-edge life 
science companies 
at MichBio 
Two new companies, Michigan Virtual BioPharma Company, LLC, and Michigan 
Virtual Medical Device Company, LLC, were launched Tuesday by the Michigan 
Life Science Network (MLSN), a group working to elevate the state's 650 biotech 
companies and medical device manufacturers as leaders of life science innovation 
and production in the global marketplace. The new companies create two new 
separate networks that get life science products to market faster, more efficiently, 
and for less money than traditional practice. Both networks use Crowdsourcing, a 
web based tool that enables each company to fill in their piece of the collaboration 
puzzle whether it be research, clinical trials, or manufacturing capabilities. From 
there, a virtual company is created that leverages the strengths of each individual 
business. 
25-Oct-07 West Michigan 
company launches 
two virtual life 
science ventures, 
seven jobs 
Of the 650 estimated biotech and medical device businesses in Michigan, 313 of 
them want in on creating two virtual companies to elevate the state as a leader of 
life science innovation and production in the global marketplace. The response 
came after an announcement made last week at MichBio, Michigan's largest 
gathering of life science experts, educators, and investors. Michigan Life Science 
Network (MLSN) announced its intent to create Michigan Virtual BioPharma 
Company, LLC, and Michigan Virtual Medical Device Company. By leveraging 
each company's capabilities—research, legal services, manufacturing, or others—
and connecting them with the capabilities of other biotech companies, the virtual 
companies will get life science products to market faster, more efficiently, and for 
less money than traditional methods. 
8-Nov-07 State announces 
initiative to retain 
Pfizer's life science 
resources 
In an effort to retain the human talent and scientific equipment left in the wake of 
Pfizer's downsizing of workforce and facilities, Michigan Governor Jennifer 
Granholm announced last week that the Michigan Strategic Fund (MSF) board has 
appointed Zeeland-based Lakeshore Advantage, an economic development 
corporation, as one of four EDCs to make loan recommendations for the $8-plus 
million Company Formation and Growth Fund. The MSF created the fund to 
finance opportunities to accelerate company growth and create new businesses that 
establish biotech or life science-related jobs for former Pfizer employees, or use 
technologies and high-tech equipment connected with Pfizer's closed facilities in 
Holland, Kalamazoo, Plymouth Township, and Portage. 
15-Nov-07 Van Andel Institute 
awarded $400K for 
groundbreaking 
breast cancer 
research 
Concept Award grants from the US Department of Defense Breast Cancer 
Research Program (BCRP) are difficult to land. Yet three researchers at the Van 
Andel Institute received grants totaling over $400,000 to help fund their 
groundbreaking breast cancer investigations. 
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29-Nov-07 Grand Rapids lab 
among first to offer 
highly specialized 
breast cancer test 
Illustrating Grand Rapids' evolution as an epicenter for advanced health care, the 
Center for Molecular Medicine (CMM) announced last week that it is the only lab 
in Michigan to offer a test that identifies and counts circulating tumor cells (CTCs) 
in the bloodstream of patients with stage IV, or metastatic, breast cancer. 
10-Jan-08 $500K infant 
incubator 
revolutionizes 
preemie healthcare 
in West Michigan 
Helen DeVos Children's Hospital added a revolutionary new medical device to its 
neonatal intensive care unit (NICU), providing cutting-edge technological 
capabilities for the detection of brain injuries or abnormalities in even the smallest 
babies. Only ten units are in operation in the United States. 
10-Jan-08 MSU, St. Mary's 
lure new medical 
talent to Grand 
Rapids 
Saint Mary's Health Care and the MSU College of Human Medicine have 
appointed their first leader of a newly created neurological services initiative. 
Christopher C. Glisson, DO, MS is the new medical director of Saint Mary's Health 
Care's innovative new neuro-opthalmology program, and he will be the MSU med 
school's assistant professor of neurology and ophthalmology. The Hauenstein 
Neurosciences Center currently under construction at St. Mary's will be completed 
in 2009 and will offer Dr. Glisson and his scientific team opportunities to delve 
into and help develop emerging neuro-ophthalmologic techniques, with a focus on 
those related to multiple sclerosis and neuro-degenerative diseases. 
17-Jan-08 Growth at Spectrum 
Health spurs 500 
clinical healthcare 
positions by year's 
end 
By the end of 2008, Spectrum Health expects to create and fill 500 full-time-
equivalent clinical healthcare positions. While most of those jobs will be system-
wide, Spectrum has earmarked some for its state-of-the-art Lemmen-Holton Cancer 
Pavilion, slated to open on June 30. 
24-Jan-08 Saint Mary's adding 
3 radiologists to 
expanded nuclear 
medicine 
department 
Next September, the new PET scanner and nuclear medicine addition at Saint 
Mary's Health Care in Grand Rapids will be up and running. And so will three new 
radiology technologist jobs the hospital expects to create to handle the increased 
number of patients. 
31-Jan-08 Two Grand Rapids 
hospitals pioneer 
treatment to help 
kids with cerebral 
palsy 
A neurosurgery never before available in West Michigan—limited exposure 
selective dorsal rhizotomy—offers children suffering from spasticity the chance to 
walk easier. A partnership between Helen DeVos Children’s Hospital (HDVCH) 
and Mary Free Bed Rehabilitation Hospital furthers the cause by offering a 
comprehensive physical therapy program for pediatric patients undergoing the 
surgery. 
31-Jan-08 Growing Center for 
Molecular Medicine 
develops 3 key 
knowledge jobs 
In existence since late 2006, The Center for Molecular Medicine (CMM) already 
has added three experienced medical technologists to handle the influx of 
molecular research. Their expertise spans a range of medical specialties, including 
molecular and cell biology, biotechnology, molecular biology, and clinical 
laboratory science. 
                                                                  Vander Woude/Bioscience and Economic Development 
  58 
7-Feb-08 New women’s 
health research lab 
taking shape on 
Medical Mile 
Another medical milestone was laid last week in Grand Rapids with the 
announcement of a collaborative effort culminating in a cutting-edge laboratory 
dedicated to the research of women’s health issues. The lab is a joint effort of 
GVSU, Michigan State University’s College of Human Medicine, the West 
Michigan Science & Technology Initiative, and Spectrum Health.  One year ago, 
the three institutions signed an agreement to collaborate on future research and 
academic projects by sharing resources and talent. 
   
By mid-February, workers will begin establishing the lab on the fifth floor of the 
GVSU Cook-DeVos Center for Health Sciences. The lab will address a broad 
range of research on women’s health issues by a team of researchers led by Dr. 
Richard E. Leach, the MSU College of Human Medicine chair for obstetrics, 
gynecology, and reproductive biology.  Researchers will have dedicated wet lab 
space as well as the use of existing WMSTI space already outfitted with 100 pieces 
of lab equipment.  
14-Feb-08 With 150 job 
openings, Perrigo 
aims to attract 
skilled workers 
back to West 
Michigan 
Perrigo Company has gotten plenty creative in its quest to attract highly skilled 
pharmaceutical workers to fill approximately 40 positions at its Allegan plant, and 
many of the workers it is talking with are former Pfizer employees from all over 
West Michigan. Perrigo has an additional 110 non-pharmaceutical jobs to fill due 
to the company's fast-paced growth driven by new product offerings and the 
acquisition of Galpharm, a pharmaceutical company in the U.K. 
14-Feb-08 WIRED moves 
West Michigan into 
next phase of 
transition to the 
Digital Age 
On February 1, the workgroups in the Workforce Innovation in Regional Economic 
Development (WIRED) initiative moved into their next phase of spurring West 
Michigan toward establishing a reputable knowledge economy workforce.    
 
WIRED West Michigan launched 12 workgroups, or 'innovations,' to spur the 
transformation of the regional economy from a manufacturing base to one 
organized more directly around technology, creativity, and knowledge. The 
initiative is funded by a $15 million federal grant that runs out on February 1, 
2009.  
28-Feb-08 Grand Rapids 
business leader 
creates online 
networking tool for 
small businesses 
On March 31, Grand Rapids businesswoman Donna Wilson will launch an 
innovative virtual business community that helps cash-strapped, schedule-tight 
small business owners generate market exposure, land new clients, and boost their 
bottom line – all through online networking and referrals.  Wilson's management 
consulting firm I-Core Networks and Milync Digital Design created the new virtual 
business community, MyCitySources.com. The site provides a variety of tools to 
help members reach their target market and other members who can refer them to 
potential clients. 
6-Mar-08 Center for 
Molecular Medicine 
pioneers prostate 
cancer test 
A new FDA-approved blood test, the CellSearch System, can aid in the treatment 
of metastatic prostate cancer, and the Grand Rapids-based Center for Molecular 
Medicine (CMM) is one of the first labs in the country to offer it, illustrating the 
city's ongoing rise a hub for medical research and innovation. 
6-Mar-08 VAI researchers 
discover method to 
slow kidney cancer 
growth 
It turns out that LEPIMAT, a lethal toxin that causes anthrax, actually slows the 
growth of a common human kidney cancer called clear cell renal cell carcinoma. 
That is what researchers at Van Andel Research Institute (VARI) recently 
discovered while testing the toxin on mice. 
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20-Mar-08 Saint Mary's 
steadily builds 
talented staff for 
new neurological 
center 
Last week, Saint Mary's Health Care announced the appointment of Deborah F. 
Gelinas, MD, as director of clinical neuroscience research. Dr. Gelinas specializes 
in ALS and will head up research at the new ALS Clinic at Mary Free Bed 
Rehabilitation Hospital.  She fills only one of nine top medical positions created by 
the development of Saint Mary's Hauenstein Center, scheduled to open in January 
2009. Five of those positions are still open.  The 14,000-square-foot Hauenstein 
Center will be West Michigan's premier location for the diagnosis and treatment of 
neurological disorders and injuries.  
Johnson Wood (2007-2008) 
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